Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Axsome Therapeutics
Axsome Therapeutics
(AXSM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Auvelity
Bupropion
,
Dextromethorphan
2022-08-18
2023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rizatriptan
migraine disorders
,
headache
,
epilepsy
,
recurrence
Dextromethorphan
respiratory tract infections
,
common cold
Bupropion
tobacco use disorder
,
cigarette smoking
,
smoking cessation
,
alzheimer disease
,
dementia
,
psychomotor agitation
,
treatment-resistant depressive disorder
,
depression
,
major depressive disorder
,
depressive disorder
,
recurrence
Meloxicam
migraine disorders
Glutamic acid
hyperkinesis
,
attention deficit disorder with hyperactivity
,
aggression
,
impulsive behavior
Esreboxetine
depression
,
major depressive disorder
,
depressive disorder
Reboxetine
fecal incontinence
,
substance-related disorders
,
amphetamine-related disorders
,
mood disorders
,
urinary incontinence
,
stress urinary incontinence
,
enuresis
,
peripheral nervous system diseases
,
neuralgia
,
postherpetic neuralgia
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
diabetic neuropathies
,
post-traumatic stress disorders
,
traumatic stress disorders
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
fibromyalgia
,
narcolepsy
,
cataplexy
,
sleepiness
,
myofascial pain syndromes
,
disorders of excessive somnolence
,
dementia
,
psychophysiologic disorders
,
anxiety disorders
,
somatoform disorders
,
fatigue
,
pain
,
depression
,
major depressive disorder
,
depressive disorder
,
schizophrenia
,
abdominal pain
,
hypersensitivity
,
stroke
,
panic disorder
,
healthy volunteers/patients
,
decision making
Tiratricol
tobacco use disorder
,
cigarette smoking
,
smoking cessation
,
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
alzheimer disease
,
dementia
,
psychomotor agitation
D-glutamate
hyperkinesis
,
attention deficit disorder with hyperactivity
,
aggression
,
impulsive behavior
Buproprion
healthy volunteers/patients
,
bipolar disorder
,
binge drinking
,
second primary neoplasms
,
alcoholism
,
non-small-cell lung carcinoma
,
lung neoplasms
,
mood disorders
,
hiv infections
,
substance-related disorders
,
smoking cessation
,
smoking
,
treatment-resistant depressive disorder
,
alzheimer disease
,
dementia
,
crohn disease
,
huntington disease
,
chorea
,
depressive disorder
,
major depressive disorder
,
depression
,
tobacco use disorder
Wellbutrin
tobacco use disorder
,
cigarette smoking
,
smoking cessation
,
alzheimer disease
,
dementia
,
psychomotor agitation
,
treatment-resistant depressive disorder
,
depression
,
major depressive disorder
,
depressive disorder
,
recurrence
Nicoderm
schizophrenia
,
crohn disease
,
cardiovascular diseases
,
coronary disease
,
diabetes mellitus
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
peripheral arterial disease
,
peripheral vascular diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use